BioPharma Resources

Drugs by condition

Drugs approved for rsv

Brand-name prescription drugs and biologics whose FDA label lists rsv as an approved use. Matched on the label phrases: "respiratory syncytial virus".

Last checked: Nov 19, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations

Brand-name drugs approved

2

Still marketed, NDA or BLA

Drug classes

1

Novel drugs

2

New molecular entities and new biologics

In development

22

Investigational drugs in Phase 2 or 3

Newest approvals

The most recently first-approved brand-name drugs for rsv.

  • Enflonsia (Clesrovimab-Cfor) · Merck Sharp Dohme NovelPriority reviewJun 9, 2025
  • Beyfortus (Nirsevimab-Alip) · Astrazeneca Ab NovelJul 17, 2023

All approved drugs for rsv, by class

Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 0 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.

Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody (2)

  • Enflonsia Clesrovimab-Cfor · Merck Sharp Dohme · 2025
  • Beyfortus Nirsevimab-Alip · Astrazeneca Ab · 2023

Drugs in development for rsv

Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.

Search the pipeline
  • CHO Cellrecombinant zoster vaccine, Recombinant Respiratory Syncytial Virus VaccinePhase 39 trials

    MAXVAX Biotechnology Limited Liability Company · Herpes Zoster, Respiratory Syncytial Virus (RSV), Herpes Zoster (HZ)

  • RSVpreFRESPIRATORY SYNCYTIAL VIRUS PREFUSION F SUBUNIT VACCINE, PF-06928316Phase 38 trials

    Pfizer · Respiratory Syncytial Virus (RSV), Lower Respiratory Tract Illness, Adult

  • RSVpreF VaccinePhase 33 trials

    Pfizer · Respiratory Syncytial Virus, Respiratory Syncytial Virus (RSV)

  • GSK · Respiratory Syncytial Virus Infections

  • RSVPreF3 OA vaccinePhase 32 trials

    GSK · Respiratory Syncytial Virus Infections

  • su vaccineRZVPhase 32 trials

    GSK · Herpes Zoster, Respiratory Syncytial Virus (RSV)

  • TNM001Phase 32 trials

    Zhuhai Trinomab Pharmaceutical Co., Ltd. · Respiratory Syncytial Virus Infections

  • zelicapavirPhase 32 trials

    Enanta Pharmaceuticals, Inc · RSV, RSV Infection, Respiratory Syncytial Virus (RSV)

  • ZiresovirAK0529Phase 32 trials

    Shanghai Ark Biopharmaceutical Co., Ltd. · Respiratory Syncytial Virus Infections, Respiratory Synctial Virus Infections

  • LYB005Phase 31 trial

    Guangzhou Patronus Biotech Co., Ltd. · Respiratory Syncytial Virus (RSV), Respiratory Syncytial Virus (RSV) Infection, RSV Vaccine

  • GSK · Cardiovascular Disease, Respiratory Syncytial Virus Infections

  • hMPV vaccinePhase 22 trials

    Sanofi · Human Metapneumovirus Immunization, Respiratory Syncytial Virus Immunization, Healthy Volunteers

  • RSV vaccine candidatePhase 22 trials

    Sanofi · Respiratory Syncytial Virus Infection, Healthy Volunteers, Respiratory Syncytial Virus Immunization

  • ABO1105Phase 21 trial

    Suzhou Abogen Biosciences Co., Ltd. · Respiratory Syncytial Virus

  • AZD6489Phase 21 trial

    AstraZeneca · RSV Respiratory Syncytial Virus

  • BLB-201PIV5-vectored RSV VaccinePhase 21 trial

    Blue Lake Biotechnology Inc. · Respiratory Syncytial Virus Infections

  • EDP-938Phase 21 trial

    Enanta Pharmaceuticals, Inc · RSV Infection

  • SCB-1019TPhase 21 trial

    Clover Biopharmaceuticals AUS Pty · RSV Infection, Human Metapneumovirus Infection, Parainfluenza Infection

  • SCB-1022Phase 21 trial

    Clover Biopharmaceuticals AUS Pty · RSV Infection, Human Metapneumovirus Infection, Parainfluenza Infection

  • SCB-1033Phase 21 trial

    Clover Biopharmaceuticals AUS Pty · RSV Infection, Human Metapneumovirus Infection, Parainfluenza Infection

More on rsv: recruiting trials · published research

Related in infectious disease and vaccines: HIV · Hepatitis B · Hepatitis C · COVID-19 · Influenza · Urinary tract infection · Pneumonia · Skin infections · C. difficile infection · Fungal infections

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.